[144] United States Cellular Corporation 5.500% Senior Notes due 2070 SEC Filing
Form 144 notice for United States Cellular Corporation (UZE). The filer reports a proposed sale of 1,960 common shares, acquired as vested RSAs on 08/01/2025 with payment characterized as equity compensation. The aggregate market value of the shares at reporting is $148,372.00, against 53,000,000 shares outstanding. The seller lists an approximate sale date of 08/18/2025 and the sale is to be executed through Charles Schwab Corp. on the NYSE. The filing states there were no securities sold by the seller in the past three months and includes the seller's certification about lack of undisclosed material information.
Avviso Form 144 per United States Cellular Corporation (UZE). Il dichiarante segnala la proposta di vendita di 1.960 azioni ordinarie, acquisite come RSAs maturate il 01/08/2025 e pagate come compenso in azioni. Il valore di mercato complessivo delle azioni al momento della segnalazione è di $148.372,00, su un totale di 53.000.000 azioni in circolazione. Il venditore indica una data approssimativa di vendita del 18/08/2025 e l’operazione sarà eseguita tramite Charles Schwab Corp. sul NYSE. La comunicazione dichiara che il venditore non ha venduto titoli negli ultimi tre mesi e include la sua certificazione sull’assenza di informazioni materiali non divulgate.
Aviso Formulario 144 para United States Cellular Corporation (UZE). El declarante informa sobre la propuesta de venta de 1.960 acciones ordinarias, adquiridas como RSAs devengadas el 01/08/2025 y pagadas como compensación en acciones. El valor de mercado agregado de las acciones al momento del informe es de $148,372.00, frente a 53,000,000 acciones en circulación. El vendedor indica una fecha aproximada de venta del 18/08/2025 y la venta se realizará a través de Charles Schwab Corp. en la NYSE. La presentación declara que el vendedor no vendió valores en los últimos tres meses e incluye la certificación del vendedor sobre la ausencia de información material no divulgada.
United States Cellular Corporation (UZE)용 Form 144 통지. 제출인은 1,960 보통주 매각 예정임을 보고했으며, 해당 주식은 2025-08-01에 완전 취득된 RSA로 취득되었고 지급 형태는 주식 보상으로 분류됩니다. 보고 시점의 주식 총 시가총액은 $148,372.00이고, 발행 주식 수는 53,000,000주입니다. 매도인은 약식 매각 예정일을 2025-08-18로 기재했으며 매매는 NYSE에서 Charles Schwab Corp.를 통해 이루어질 예정입니다. 보고서에는 매도인이 지난 3개월 동안 매도한 증권이 없음을 기재하고 있으며, 미공개 중요 정보가 없음을 확인하는 인증서가 포함되어 있습니다.
Avis Formulaire 144 pour United States Cellular Corporation (UZE). Le déposant signale une vente projetée de 1 960 actions ordinaires, acquises en tant que RSAs acquises le 01/08/2025 et dont le paiement est qualifié de rémunération en actions. La valeur marchande agrégée des actions au moment du rapport est de 148 372,00 $, sur 53 000 000 actions en circulation. Le vendeur indique une date de vente approximative au 18/08/2025 et la transaction sera exécutée via Charles Schwab Corp. sur le NYSE. Le dépôt précise qu’aucun titre n’a été vendu par le vendeur au cours des trois derniers mois et inclut la certification du vendeur quant à l’absence d’informations matérielles non divulguées.
Formular 144-Mitteilung für United States Cellular Corporation (UZE). Der Einreichende meldet einen geplanten Verkauf von 1.960 Stammaktien, erworben als gevestete RSAs am 01.08.2025, mit der Zahlung als Aktienvergütung. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung beträgt $148.372,00, bei insgesamt 53.000.000 ausstehenden Aktien. Der Verkäufer gibt ein ungefähres Verkaufsdatum von 18.08.2025 an; der Verkauf soll über Charles Schwab Corp. an der NYSE ausgeführt werden. Die Einreichung besagt, dass der Verkäufer in den letzten drei Monaten keine Wertpapiere verkauft hat und enthält die Bestätigung des Verkäufers über das Fehlen nicht offengelegter wesentlicher Informationen.
- Clear disclosure of number of shares to be sold (1,960) and aggregate market value ($148,372.00)
- Transaction source disclosed as vested RSAs with equity compensation payment characterization
- Broker and market specified: Charles Schwab Corp. on the NYSE, with an approximate sale date of 08/18/2025
- Seller attestation that there is no undisclosed material adverse information and statement that no securities were sold in the past three months
- Filer contact and issuer identification fields appear incomplete or blank in the provided content
- Filing contains minimal context about the seller's identity or any trading plan details beyond the basic attestation
Insights
TL;DR: A small equity-compensation share sale is planned and appears routine, with limited direct impact on company capital structure.
The notice documents a proposed disposition of 1,960 common shares obtained as vested restricted stock awards on 08/01/2025. The transaction is scheduled through Charles Schwab on the NYSE on or about 08/18/2025, with an aggregate reported market value of $148,372.00. The filing reports no sales by the holder in the last three months and includes the standard attestation of no undisclosed material information. From a capital-markets perspective, this appears to be an individual insider's routine sale of vested equity rather than a corporate financing event.
TL;DR: Document is a standard compliance filing for insider sales tied to equity compensation, emphasizing required attestations.
The Form 144 discloses that the securities to be sold were acquired as vested RSAs and that the seller certifies absence of undisclosed material information. The form lists the broker and an approximate sale date, and explicitly notes no securities sold in the prior three months by the same person. The filing fulfills Rule 144 notification requirements and includes the statutory warning about intentional misstatements. No governance red flags or material compliance exceptions are apparent from the notice itself.
Avviso Form 144 per United States Cellular Corporation (UZE). Il dichiarante segnala la proposta di vendita di 1.960 azioni ordinarie, acquisite come RSAs maturate il 01/08/2025 e pagate come compenso in azioni. Il valore di mercato complessivo delle azioni al momento della segnalazione è di $148.372,00, su un totale di 53.000.000 azioni in circolazione. Il venditore indica una data approssimativa di vendita del 18/08/2025 e l’operazione sarà eseguita tramite Charles Schwab Corp. sul NYSE. La comunicazione dichiara che il venditore non ha venduto titoli negli ultimi tre mesi e include la sua certificazione sull’assenza di informazioni materiali non divulgate.
Aviso Formulario 144 para United States Cellular Corporation (UZE). El declarante informa sobre la propuesta de venta de 1.960 acciones ordinarias, adquiridas como RSAs devengadas el 01/08/2025 y pagadas como compensación en acciones. El valor de mercado agregado de las acciones al momento del informe es de $148,372.00, frente a 53,000,000 acciones en circulación. El vendedor indica una fecha aproximada de venta del 18/08/2025 y la venta se realizará a través de Charles Schwab Corp. en la NYSE. La presentación declara que el vendedor no vendió valores en los últimos tres meses e incluye la certificación del vendedor sobre la ausencia de información material no divulgada.
United States Cellular Corporation (UZE)용 Form 144 통지. 제출인은 1,960 보통주 매각 예정임을 보고했으며, 해당 주식은 2025-08-01에 완전 취득된 RSA로 취득되었고 지급 형태는 주식 보상으로 분류됩니다. 보고 시점의 주식 총 시가총액은 $148,372.00이고, 발행 주식 수는 53,000,000주입니다. 매도인은 약식 매각 예정일을 2025-08-18로 기재했으며 매매는 NYSE에서 Charles Schwab Corp.를 통해 이루어질 예정입니다. 보고서에는 매도인이 지난 3개월 동안 매도한 증권이 없음을 기재하고 있으며, 미공개 중요 정보가 없음을 확인하는 인증서가 포함되어 있습니다.
Avis Formulaire 144 pour United States Cellular Corporation (UZE). Le déposant signale une vente projetée de 1 960 actions ordinaires, acquises en tant que RSAs acquises le 01/08/2025 et dont le paiement est qualifié de rémunération en actions. La valeur marchande agrégée des actions au moment du rapport est de 148 372,00 $, sur 53 000 000 actions en circulation. Le vendeur indique une date de vente approximative au 18/08/2025 et la transaction sera exécutée via Charles Schwab Corp. sur le NYSE. Le dépôt précise qu’aucun titre n’a été vendu par le vendeur au cours des trois derniers mois et inclut la certification du vendeur quant à l’absence d’informations matérielles non divulguées.
Formular 144-Mitteilung für United States Cellular Corporation (UZE). Der Einreichende meldet einen geplanten Verkauf von 1.960 Stammaktien, erworben als gevestete RSAs am 01.08.2025, mit der Zahlung als Aktienvergütung. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung beträgt $148.372,00, bei insgesamt 53.000.000 ausstehenden Aktien. Der Verkäufer gibt ein ungefähres Verkaufsdatum von 18.08.2025 an; der Verkauf soll über Charles Schwab Corp. an der NYSE ausgeführt werden. Die Einreichung besagt, dass der Verkäufer in den letzten drei Monaten keine Wertpapiere verkauft hat und enthält die Bestätigung des Verkäufers über das Fehlen nicht offengelegter wesentlicher Informationen.